Akso Health Group Offering 37.1M ADS Shares, Representing Three Ordinary Shares, Directly To Institutional Investors At Price Per ADS Of $1.33
Akso Health Group Offering 37.1M ADS Shares, Representing Three Ordinary Shares, Directly To Institutional Investors At Price Per ADS Of $1.33
- SEC Filing
-美國證券交易委員會備案
AKSO HEALTH GROUP
AKSO 健康集團
37,100,000 American Depositary Shares
37,100,000 股美國存托股票
Representing 111,300,000 Ordinary Shares
代表111,300,000股普通股
We are offering 37,100,000 of our American depositary shares, or ADSs, each representing three ordinary shares, par value $0.0001 per share, directly to certain institutional investors pursuant to that certain Securities Purchase Agreement, dated March 5, 2024, at a price per ADS of $1.33. In a concurrent private placement, we are also selling to the investors warrants to purchase an aggregate of up to 222,600,000 of our ordinary shares. The warrants are exercisable immediately as of the date of issuance at an exercise price of $0.4933 per ordinary share, or $1.48 per ADS and expire five years from the date of issuance. The warrants and the ordinary shares issuable upon the exercise of the warrants are not being registered under the Securities Act of 1933, as amended, or the Securities Act, pursuant to the registration statement of which this prospectus supplement and the accompanying prospectus. The warrants and the ordinary shares issuable upon the exercise of the warrants are being offered pursuant to an exemption from the registration requirements of the Securities Act provided in Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D.
根據2024年3月5日的某些證券購買協議，我們將直接向某些機構投資者發行37,100,000股美國存托股票（ADS），每股代表三股普通股，面值0.0001美元，每股價格爲1.33美元。在同時進行的私募中，我們還向投資者出售認股權證，以購買總額高達222,600,000股普通股。認股權證自發行之日起可立即行使，行使價爲每股普通股0.4933美元，合每股ADS1.48美元，自發行之日起五年內到期。根據本招股說明書補充文件和隨附的招股說明書的註冊聲明，認股權證和行使認股權證時可發行的普通股未根據經修訂的1933年《證券法》或《證券法》進行註冊。認股權證和行使認股權證時可發行的普通股是根據《證券法》第4（a）（2）條和/或D條例第506（b）條規定的《證券法》註冊要求的豁免發行的。
The aggregate market value of our outstanding ordinary held by non-affiliates, or public float, was approximately $276.52 million, which was calculated based on Ordinary Shares outstanding held by non-affiliates and a price per ADS of $2.60, which was the last reported price on the Nasdaq Capital Market of our ADS on February 2, 2024.
我們非關聯公司持有的已發行普通股或公衆持股量的總市值約爲2.7652億美元，這是根據非關聯公司持有的已發行普通股和每股ADS的價格2.60美元計算得出的，這是我們ADS於2024年2月2日在納斯達克資本市場上最後公佈的價格。
Our ADSs are currently traded on the Nasdaq Capital Market, or Nasdaq, under the symbol "AHG." On March 5, 2024, the closing sale price of our ADSs was $1.23 per ADS.
我們的ADS目前在納斯達克資本市場（納斯達克）上市，股票代碼爲 “AHG”。2024年3月5日，我們的ADS的收盤銷售價格爲每張ADS1.23美元。
We expect that delivery of the ADSs being offered pursuant to this prospectus supplement and the accompanying prospectus will be made on or about March 7, 2024.
我們預計，根據本招股說明書補充文件和隨附的招股說明書發行的美國存託憑證將在2024年3月7日左右交付。
譯文內容由第三人軟體翻譯。